Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Geser

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
The Unified Multiple System Atrophy Rating Scale: intrarater reliabilityFlorian Krismer, Klaus Seppi, François Tison, et al.
Archives of Neurology|February 11, 2009
Clinical and pathological continuum of multisystem TDP-43 proteinopathiesFelix Geser, Maria Martinez-Lage, John Robinson, et al.
Annals of Neurology|May 1, 2007
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsIan R A Mackenzie, Eileen H Bigio, Paul G Ince, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2005
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)Felix Geser, Gregor K Wenning, Klaus Seppi, et al.
Nature|August 27, 2010
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSAndrew C Elden, Hyung-Jun Kim, Michael P Hart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 28, 2006
Health-related quality of life in multiple system atrophyAnette Schrag, Felix Geser, Michaela Stampfer-Kountchev, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
Red flags for multiple system atrophyMartin Köllensperger, Felix Geser, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2010
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registryMartin Köllensperger, Felix Geser, Jean-Pierre Ndayisaba, et al.
The Lancet. Neurology|February 9, 2013
The natural history of multiple system atrophy: a prospective European cohort studyGregor K Wenning, Felix Geser, Florian Krismer, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
The Unified Multiple System Atrophy Rating Scale: intrarater reliabilityFlorian Krismer, Klaus Seppi, François Tison, et al.
Archives of Neurology|February 11, 2009
Clinical and pathological continuum of multisystem TDP-43 proteinopathiesFelix Geser, Maria Martinez-Lage, John Robinson, et al.
Annals of Neurology|May 1, 2007
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsIan R A Mackenzie, Eileen H Bigio, Paul G Ince, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2005
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)Felix Geser, Gregor K Wenning, Klaus Seppi, et al.
Nature|August 27, 2010
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSAndrew C Elden, Hyung-Jun Kim, Michael P Hart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 28, 2006
Health-related quality of life in multiple system atrophyAnette Schrag, Felix Geser, Michaela Stampfer-Kountchev, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
Red flags for multiple system atrophyMartin Köllensperger, Felix Geser, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2010
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registryMartin Köllensperger, Felix Geser, Jean-Pierre Ndayisaba, et al.
The Lancet. Neurology|February 9, 2013
The natural history of multiple system atrophy: a prospective European cohort studyGregor K Wenning, Felix Geser, Florian Krismer, et al.
Pageof 5